Literature DB >> 14768020

Hy's law.

Adrian Reuben1.   

Abstract

Mesh：

Year:  2004        PMID： 14768020     DOI： 10.1002/hep.20081

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  47 in total

1.  Squalene synthase inhibitor lapaquistat acetate: could anything be better than statins?

Authors:  James K Liao
Journal:  Circulation       Date:  2011-04-25       Impact factor: 29.690

2.  Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trial.

Authors:  Emiliano Calvo; Analia Azaro; Jordi Rodon; Luc Dirix; Manon Huizing; Francis Mark Senecal; Patricia LoRusso; Lorrin Yee; Italo Poggesi; Jan de Jong; Spyros Triantos; Youn C Park; Roland E Knoblauch; Trilok V Parekh; George D Demetri; Margaret von Mehren
Journal:  Invest New Drugs       Date:  2017-11-27       Impact factor: 3.850

Review 3.  The Origins of the Modern-Day Study of Drug Hepatotoxicity: Focus on Hyman J. Zimmerman.

Authors:  James H Lewis; Leonard B Seeff
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-02

4.  Laquinimod Safety Profile: Pooled Analyses from the ALLEGRO and BRAVO Trials.

Authors:  Per Soelberg Sørensen; Giancarlo Comi; Timothy L Vollmer; Xavier Montalban; Ludwig Kappos; Yuval Dadon; Tali Gorfine; Maya Margalit; Nissim Sasson; Svetlana Rubinchick; Volker Knappertz
Journal:  Int J MS Care       Date:  2017 Jan-Feb

Review 5.  Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives.

Authors:  Rashmi R Shah; Joel Morganroth; Devron R Shah
Journal:  Drug Saf       Date:  2013-07       Impact factor: 5.606

6.  Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE).

Authors:  Sibylle Loibl; Lorena de la Pena; Valentina Nekljudova; Dimitrios Zardavas; Stefan Michiels; Carsten Denkert; Mahdi Rezai; Begoña Bermejo; Michael Untch; Soo Chin Lee; Sabine Turri; Patrick Urban; Sherko Kümmel; Guenther Steger; Andrea Gombos; Michael Lux; Martine J Piccart; Gunter Von Minckwitz; José Baselga; Sherene Loi
Journal:  Eur J Cancer       Date:  2017-09-17       Impact factor: 9.162

7.  Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitis.

Authors:  John D Clarke; Tatiana Sharapova; April D Lake; Eric Blomme; Jonathan Maher; Nathan J Cherrington
Journal:  J Appl Toxicol       Date:  2013-11-12       Impact factor: 3.446

8.  Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke.

Authors:  Patrick Lyden; Kent E Pryor; Christopher S Coffey; Merit Cudkowicz; Robin Conwit; Ashutosh Jadhav; Robert N Sawyer; Jan Claassen; Opeolu Adeoye; Shlee Song; Peter Hannon; Natalia S Rost; Archana Hinduja; Michel Torbey; Jin-Moo Lee; Curtis Benesch; Michael Rippee; Marilyn Rymer; Michael T Froehler; E Clarke Haley; Mark Johnson; Jon Yankey; Kim Magee; Julie Qidwai; Howard Levy; E Mark Haacke; Miller Fawaz; Thomas P Davis; Arthur W Toga; John H Griffin; Berislav V Zlokovic
Journal:  Ann Neurol       Date:  2019-01-07       Impact factor: 10.422

9.  Uncommon Cause of Acute Drug-induced Liver Injury Following Mammoplasty.

Authors:  Atul Singla; Hazem T Hammad; Ghassan M Hammoud
Journal:  Gastroenterology Res       Date:  2010-07-20

10.  Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease.

Authors:  Shinya Goto; Hisao Ogawa; Masaru Takeuchi; Marcus D Flather; Deepak L Bhatt
Journal:  Eur Heart J       Date:  2010-08-30       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.